constipation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female between 18 and 80 years of age; 2. A patient with a urinary tract tumor undergoing surgical resection; 3. Patients voluntarily participated in this study and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. 5 times of the upper normal value of > for aspartate aminotransferase (AST) or alanine aminotransferase (ALT); 2. Serum creatinine value of > is 2 times the upper limit of normal; 3. Paraplegia or tumor compression of the rectum due to trauma or surgery caused by defecation disorders; 4. Mental or neurological disorders, unable to express their wishes correctly; 5. Pregnant women, lactating women and women of childbearing age who do not take contraceptive measures; 6. Those deemed unsuitable for inclusion by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients with spontaneous complete bowel movements (SCBM >= 3 times within 7 days of prevention or treatment during the survey period (SCBM >= 3 times is considered normal bowel movements); | — |
Secondary
| Measure | Time frame |
|---|---|
| Compared with before treatment, the proportion of patients with SCBM more than once within 7 days of prevention or treatment increased;Proportion of patients with SCBM or SBM within 7 days of prevention or treatment;Difference in constipation symptom scores at 7 days of prevention or treatment compared with pre-medication;Compared with before treatment, the proportion of patients whose QOL score of constipation patients improved by more than 1 after 7 days of prevention or treatment;incidence of adverse events related to cathartic; | — |
Countries
China
Contacts
Cancer Hospital Chinese Academy of Medical Sciences